One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature
Adam B.WeineraAisha L.SiebertaSarah E.FentonbWassimAbidacNeerajAgarwaldIan D.DavisefgTanya B.DorffhMartinGleaveiNicholas D.JamesjDarren M.C.PoonkHiroyoshiSuzukilChristopher J.Sweeneym
Managing Prostate Cancer Recurrence After Local Treatment: Balancing Benefits Against Risks in a Rapidly Changing Environment
BertrandTombal*
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography–targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis
TatsushiKawadaabTakafumiYanagisawaacPawelRajwaadRezaSari MotlaghaeHadiMostafaeiafFahadQuhalagEkaterinaLaukhtinaahAbdulmajeedAydhaiFrederikKönigajMaximilianPallaufakBenjaminPradereaFrancescoCecilmPascal A.T.BaltzernMarcusHackeroSazanRasuloPierre I.KarakiewiczpMotooArakibYasutomoNasubShahrokh F.Shariatahqrstu
Better To Rule In or Rule Out Significant Prostate Cancer? The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography to Magnetic Resonance Imaging Diagnostic Pathways for Prostate Cancer
JochenWalz
Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations
Patrick J.HensleyaValeriaPanebiancobEugenePietzakcAlexanderKutikovdRaghuVikramaMatthew D.GalskyeShahrokh F.ShariatfghiMorganRoupretjAshish M.Kamata
Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups
RachelHursta†EmmaMeaderb†AbrahamGihawia†GhanasyamRallapallia†JeremyClarkaGemma L.KayacMartynWebbaKateManleyadHelenCurleyaHelenWalkerdRaviKumaraKatarzynaSchmidtbLisaCrossmanacRosalind A.EelesefDavid C.WedgeghAndy G.LynchijCharlie E.MassiekCRUK-ICGC Prostate Groupl…Colin S.Coopera‡
Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodexyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study
JianPanab†YuWeiab†TingweiZhangab†ChangLiubc†XiaoxinHubdJinouZhaoabHualeiGanbeWeiLiubcBinZhubcJunlongWuabBeiheWangab‡ShaoliSongbc‡DingweiYeab‡YaoZhuab‡
Another Step Towards the Acceptance of Metastasis-directed Therapy in Low-volume Metastatic Prostate Cancer
GertDe MeerleeraKatoRansaStevenJoniaubCharlienBerghena
Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer
Andi K.CaniabcdKevinHuaeChia-JenLiuacdJavedSiddiquiacYingyeZhengfSuminHanacSrinivasNallandhighalgDaniel H.HovelsonaceLanboXiaoacdTrinhPhamgNicholas W.EyrichgHengZhengacdRandyVinceJrgJeffrey J.TosoianadgGanesh S.PalapattudgTodd M.MorgandgJohn T.WeiagAaron M.Udageracd…Simpa S.Salamiadg
En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Noninferiority Trial
AndreaGalliolia†PietroDianaab†MatteoFontanaaAngeloTerritoaÓscarRodriguez-FabaaJosep MariaGayaaFrancescoSanguedolceaJordiHuguetaAsierMercadeaAlbertoPianaaJuliaAumatellaAlejandraBravo-BaladoaFerranAlgabacJoanPalouadAlbertoBredaad
En Bloc Resection of Bladder Tumours: Ready for Clinical Use?
ArnulfStenzl
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma
AlbertoMartiniaChiaraLonatibcLuigiNoceraaGiuseppeFallaraaDanieleRaggidRomanHerouteStefaniaZambonicGuillaumePloussardfBenjaminPrederefAgostinoMatteibClaudioSimeonecWojciechKrajewskigGiuseppeSimonehFrancescoSoriaiPaoloGonteroiMorganRoupretjFrancescoMontorsiaAlbertoBrigantia…MarcoMoschinia
A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy
AinaSalazaraLucasRegisabJacquesPlanasabAnnaCelmaabAnnaSantamariabEnriqueTrillaacJuanMoroteabc
Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial Carcinoma
LouisLenfantaAlbertoBredabEvangelosXylinascMarekBabjukdeMarcoMoschinifMorganRouprêtaon behalf of the EAU Section of Oncological Urology (ESOU) Board
Re: Aina Salazar, Lucas Regis, Jacques Planas, et al. A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. Eur Urol Oncol 2022;5:460–3
NikolaosKalampokisaNikolaosGrivasbMarkosKaravitakiscHenkvan der Poelb
Reply to Nikolaos Kalampokis, Nikolaos Grivas, Markos Karavitakis, and Henk van der Poel’s Letter to the Editor re: Aina Salazar, Lucas Regis, Jacques Planas, et al. A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. Eur Urol Oncol 2022;5:460–3
JuanMoroteAinaSalazarLucasRegis
Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002
Ozan CemGuleraCemOnalab
Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948–54
Ozan CemGuleraOguzhanIscibCemOnalac
Reply to Ozan Cem Guler and Cem Onal’s Letter to the Editor re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.04.005
JianPanBeiheWangYaoZhu
Corrigendum to “Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non–muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis� [Eur Urol Oncol 2021;4:927–42]
EkaterinaLaukhtinaab1Sung RyulShimc1KeiichiroMoriadDavidD'AndreaaFrancescoSoriaePawelRajwaafHadiMostafaeiagEvaCompérathAlessiaCimadamoreiMarcoMoschinijJeremy Yuen-ChunTeohkDmitryEnikeevbEvanguelosXylinaslYairLotanmJuanPalounPaoloGonteroeMarkoBabjukaoJ. AlfredWitjesp…BenjaminPraderea
